Shanghai Titan Scientific Co. Ltd. A (688133) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Shanghai Titan Scientific Co. Ltd. A (688133) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥79.65 Million ≈ $11.65 Million USD) by net assets (CN¥2.87 Billion ≈ $419.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Shanghai Titan Scientific Co. Ltd. A to measure how much of total assets are equity-financed.

Shanghai Titan Scientific Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shanghai Titan Scientific Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Shanghai Titan Scientific Co. Ltd. A's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Shanghai Titan Scientific Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Titan Scientific Co. Ltd. A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangxi Yuean Advanced Materials Co Ltd
SHG:688786
0.056x
Hanwang Technology Co Ltd
SHE:002362
-0.041x
Zhejiang Jinghua Laser Technology Co Ltd Class A
SHG:603607
0.077x
Oeneo SA
PA:SBT
0.044x
CareRay Digital Medical Technology Co Ltd
SHG:688607
-0.026x
KinderCare Learning Companies, Inc.
NYSE:KLC
0.108x
SeaBird Exploration Plc
OL:SBX
0.148x
Savita Oil Technologies Limited
NSE:SOTL
0.054x

Annual Cash Flow Conversion Efficiency for Shanghai Titan Scientific Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Titan Scientific Co. Ltd. A from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 688133 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.83 Billion
≈ $413.53 Million
CN¥237.52 Million
≈ $34.76 Million
0.084x +27.66%
2024-12-31 CN¥2.87 Billion
≈ $420.07 Million
CN¥189.01 Million
≈ $27.66 Million
0.066x +250.70%
2023-12-31 CN¥2.85 Billion
≈ $417.07 Million
CN¥-124.53 Million
≈ $-18.22 Million
-0.044x +20.16%
2022-12-31 CN¥2.77 Billion
≈ $404.85 Million
CN¥-151.39 Million
≈ $-22.15 Million
-0.055x +63.49%
2021-12-31 CN¥1.62 Billion
≈ $236.48 Million
CN¥-242.22 Million
≈ $-35.44 Million
-0.150x -57.78%
2020-12-31 CN¥1.45 Billion
≈ $212.81 Million
CN¥-138.16 Million
≈ $-20.22 Million
-0.095x -68.11%
2019-12-31 CN¥563.63 Million
≈ $82.48 Million
CN¥-31.85 Million
≈ $-4.66 Million
-0.057x -163.35%
2018-12-31 CN¥386.60 Million
≈ $56.57 Million
CN¥34.49 Million
≈ $5.05 Million
0.089x +53.40%
2017-12-31 CN¥287.35 Million
≈ $42.05 Million
CN¥16.71 Million
≈ $2.45 Million
0.058x +1556.03%
2016-12-31 CN¥199.28 Million
≈ $29.16 Million
CN¥-795.89K
≈ $-116.46K
-0.004x +94.98%
2015-12-31 CN¥177.32 Million
≈ $25.95 Million
CN¥-14.12 Million
≈ $-2.07 Million
-0.080x -175.93%
2014-12-31 CN¥109.82 Million
≈ $16.07 Million
CN¥11.52 Million
≈ $1.69 Million
0.105x +236.79%
2013-12-31 CN¥102.71 Million
≈ $15.03 Million
CN¥-7.87 Million
≈ $-1.15 Million
-0.077x --

About Shanghai Titan Scientific Co. Ltd. A

SHG:688133 China Chemicals
Market Cap
$575.09 Million
CN¥3.93 Billion CNY
Market Cap Rank
#11513 Global
#3245 in China
Share Price
CN¥23.90
Change (1 day)
+9.18%
52-Week Range
CN¥18.56 - CN¥30.16
All Time High
CN¥165.69
About

Shanghai Titan Scientific Co., Ltd. engages in the provision of laboratory products and supporting services for scientific researchers and quality control personnel. The company offers scientific research reagents, special chemicals, scientific research instruments and consumables, laboratory construction, and scientific research information services. It serves universities, hospitals, research i… Read more